Olivia B El-nemri
Examiner (ID: 14806)
Most Active Art Unit | 2938 |
Art Unit(s) | 2938 |
Total Applications | 3 |
Issued Applications | 2 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1503123
[patent_doc_number] => 06465227
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Spherical particles containing microorganism cells having enzyme activity'
[patent_app_type] => B1
[patent_app_number] => 09/508030
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10120
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465227.pdf
[firstpage_image] =>[orig_patent_app_number] => 09508030
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508030 | Spherical particles containing microorganism cells having enzyme activity | Apr 2, 2000 | Issued |
Array
(
[id] => 1290774
[patent_doc_number] => 06630333
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Substantially pure reverse transriptases and methods of production thereof'
[patent_app_type] => B1
[patent_app_number] => 09/533548
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7973
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09533548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/533548 | Substantially pure reverse transriptases and methods of production thereof | Mar 22, 2000 | Issued |
Array
(
[id] => 4379784
[patent_doc_number] => 06277610
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Rapid thermal cycle processing methods and apparatus'
[patent_app_type] => 1
[patent_app_number] => 9/508889
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 20937
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277610.pdf
[firstpage_image] =>[orig_patent_app_number] => 508889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508889 | Rapid thermal cycle processing methods and apparatus | Mar 16, 2000 | Issued |
Array
(
[id] => 1188787
[patent_doc_number] => 06734018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced'
[patent_app_type] => B2
[patent_app_number] => 09/528371
[patent_app_country] => US
[patent_app_date] => 2000-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 13109
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734018.pdf
[firstpage_image] =>[orig_patent_app_number] => 09528371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/528371 | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced | Mar 16, 2000 | Issued |
Array
(
[id] => 1440909
[patent_doc_number] => 06335196
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => '13C,15N ,2H labeled proteins for NMR structure determinations and their preparation'
[patent_app_type] => B1
[patent_app_number] => 09/486837
[patent_app_country] => US
[patent_app_date] => 2000-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7836
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335196.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486837
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486837 | 13C,15N ,2H labeled proteins for NMR structure determinations and their preparation | Mar 14, 2000 | Issued |
Array
(
[id] => 1449692
[patent_doc_number] => 06455286
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Psoralens for pathogen inactivation'
[patent_app_type] => B1
[patent_app_number] => 09/500680
[patent_app_country] => US
[patent_app_date] => 2000-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19266
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455286.pdf
[firstpage_image] =>[orig_patent_app_number] => 09500680
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/500680 | Psoralens for pathogen inactivation | Feb 8, 2000 | Issued |
Array
(
[id] => 1577590
[patent_doc_number] => 06448031
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Process for producing LH-RH derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/463947
[patent_app_country] => US
[patent_app_date] => 2000-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13700
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/448/06448031.pdf
[firstpage_image] =>[orig_patent_app_number] => 09463947
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/463947 | Process for producing LH-RH derivatives | Feb 3, 2000 | Issued |
Array
(
[id] => 1597306
[patent_doc_number] => 06492562
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Racemic thioesters for production of polyketides'
[patent_app_type] => B1
[patent_app_number] => 09/492733
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23482
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492562.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492733 | Racemic thioesters for production of polyketides | Jan 26, 2000 | Issued |
Array
(
[id] => 1523516
[patent_doc_number] => 06352852
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Method for the purification of human platelet heparanase'
[patent_app_type] => B1
[patent_app_number] => 09/490109
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14459
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09490109
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490109 | Method for the purification of human platelet heparanase | Jan 23, 2000 | Issued |
Array
(
[id] => 4302722
[patent_doc_number] => 06326197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Platelet suspensions and methods for resuspending platelets'
[patent_app_type] => 1
[patent_app_number] => 9/490191
[patent_app_country] => US
[patent_app_date] => 2000-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3961
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326197.pdf
[firstpage_image] =>[orig_patent_app_number] => 490191
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/490191 | Platelet suspensions and methods for resuspending platelets | Jan 23, 2000 | Issued |
Array
(
[id] => 1339268
[patent_doc_number] => 06589786
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-08
[patent_title] => 'Cell separation using electric fields'
[patent_app_type] => B1
[patent_app_number] => 09/489116
[patent_app_country] => US
[patent_app_date] => 2000-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 57
[patent_no_of_words] => 39287
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/589/06589786.pdf
[firstpage_image] =>[orig_patent_app_number] => 09489116
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/489116 | Cell separation using electric fields | Jan 20, 2000 | Issued |
Array
(
[id] => 1593994
[patent_doc_number] => 06383790
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'High affinity protein kinase inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/480993
[patent_app_country] => US
[patent_app_date] => 2000-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 65
[patent_no_of_words] => 43250
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/383/06383790.pdf
[firstpage_image] =>[orig_patent_app_number] => 09480993
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/480993 | High affinity protein kinase inhibitors | Jan 10, 2000 | Issued |
Array
(
[id] => 6274700
[patent_doc_number] => 20020106363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'LIPID CLEAVAGE ENZYME'
[patent_app_type] => new
[patent_app_number] => 09/472184
[patent_app_country] => US
[patent_app_date] => 1999-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17887
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106363.pdf
[firstpage_image] =>[orig_patent_app_number] => 09472184
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/472184 | LIPID CLEAVAGE ENZYME | Dec 26, 1999 | Abandoned |
09/461321 | CORE 1 BETA3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF | Dec 14, 1999 | Abandoned |
09/460025 | SPECTRAL CATALYSTS | Dec 12, 1999 | Abandoned |
Array
(
[id] => 4400062
[patent_doc_number] => 06270764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Method of treating viral hemorrhagic fever with activated protein C'
[patent_app_type] => 1
[patent_app_number] => 9/444479
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3793
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270764.pdf
[firstpage_image] =>[orig_patent_app_number] => 444479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/444479 | Method of treating viral hemorrhagic fever with activated protein C | Nov 18, 1999 | Issued |
09/439066 | METHOD OF TREATING HEPARIN-INDUCED THROMBOCYTOPENIA | Nov 11, 1999 | Abandoned |
Array
(
[id] => 1332965
[patent_doc_number] => 06592867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-15
[patent_title] => 'Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type'
[patent_app_type] => B2
[patent_app_number] => 09/437106
[patent_app_country] => US
[patent_app_date] => 1999-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8851
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/592/06592867.pdf
[firstpage_image] =>[orig_patent_app_number] => 09437106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/437106 | Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type | Nov 8, 1999 | Issued |
Array
(
[id] => 1391769
[patent_doc_number] => 06541229
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light'
[patent_app_type] => B1
[patent_app_number] => 09/418802
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5188
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541229.pdf
[firstpage_image] =>[orig_patent_app_number] => 09418802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/418802 | Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light | Oct 14, 1999 | Issued |
Array
(
[id] => 1516866
[patent_doc_number] => 06500608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-31
[patent_title] => 'Method for vitrification of biological cells'
[patent_app_type] => B2
[patent_app_number] => 09/416992
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10480
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500608.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416992 | Method for vitrification of biological cells | Oct 12, 1999 | Issued |